Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19

QD Xia, Y Xun, JL Lu, YC Lu, YY Yang, P Zhou… - Cell …, 2020 - Wiley Online Library
Abstract Objectives Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide.
Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19 …

Exploring material basis and mechanism of Lianhua Qingwen prescription against coronavirus based on network pharmacology

XY Ling - Chinese Traditional and Herbal Drugs, 2020 - pesquisa.bvsalud.org
Objective: To explore the active compounds and mechanism of Lianhua Qingwen
Prescription for the treatment of coronavirus, and provide a reference for the treatment of …

[HTML][HTML] Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking

X Ruan, P Du, K Zhao, J Huang, H Xia, D Dai… - Chinese Medicine, 2020 - Springer
Background At present, coronavirus disease 2019 (COVID-19), caused by infection with
severe acute respiratory syndrome coronavirus 2, is spreading all over the world, with …

[HTML][HTML] Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology

W Zheng, Q Yan, Y Ni, S Zhan, L Yang, H Zhuang… - BioData mining, 2020 - Springer
Abstract Background Chinese medicine Xuebijing (XBJ) has proven to be effective in the
treatment of mild coronavirus disease 2019 (COVID-19) cases. But the bioactive compounds …

Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19

Q Tao, J Du, X Li, J Zeng, B Tan, J Xu… - Drug development and …, 2020 - Taylor & Francis
Abstract Purpose Huashi Baidu formula (HSBDF) was developed to treat the patients with
severe COVID-19 in China. The purpose of this study was to explore its active compounds …

Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6

W Niu, F Wu, W Cao, Z Wu, YC Chao, F Peng… - Bioscience …, 2021 - portlandpress.com
Objective:´ Three formulas and three medicines,'namely, Jinhua Qinggan Granule, Lianhua
Qingwen Capsule, Xuebijing Injection, Qingfei Paidu Decoction, HuaShi BaiDu Formula …

[HTML][HTML] Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 …

S Zheng, JP Baak, S Li, W Xiao, H Ren, H Yang, Y Gan… - Phytomedicine, 2020 - Elsevier
Abstract Background The traditional Chinese Medicine (TCM) herbal formula Lian Hua Qing
Wen (LHQW) improves the results of COVID-19 treatment. Three very recent studies …

Exploring the treatment of COVID‐19 with Yinqiao powder based on network pharmacology

H Lin, X Wang, M Liu, M Huang, Z Shen… - Phytotherapy …, 2021 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2). In China, Yinqiao powder is widely used to prevent and treat …

[HTML][HTML] Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools

Q Kong, Y Wu, Y Gu, Q Lv, F Qi, S Gong… - Biomedicine & …, 2020 - Elsevier
Background Pudilan (PDL), a four-herb prescription with the traditional function of heat-
clearing and detoxifying, has been clinically used as an anti-SARS-CoV-2 infectory agent in …

Investigating mechanism of Qing-Fei-Pai-Du-Tang for treatment of COVID-19 by network pharmacology

J ZHAO - Chinese Traditional and Herbal Drugs, 2020 - pesquisa.bvsalud.org
Objective: To collect main ingredients and targets of Qing-Fei-Pai-Du-Tang (QFPDT), and to
investigate the relationship between the targets and coronavirus disease 2019 (COVID-19) …